MTOR and colorectal carcinoma: Some findings provide a rationale for chemotherapy targeting the PI3K/mTOR signaling pathway, providing a potential therapeutic strategy to enhance the efficacy of a dual PI3K/mTOR inhibitor in combination with an autophagy inhibitor for the treatment of CRC [259].